Evaluation of MET T1010I and MET rs40239 single-nucleotide polymorphisms in triple-negative breast cancer: a case–control study

Evaluation of MET T1010I and MET rs40239 single-nucleotide polymorphisms in triple-negative breast cancer: a case–control study

Despoina Kalapanida,1 Flora Zagouri,1 Maria Gazouli,2 Andriani Tsiakou,3 Eleni Zografos,2 Constantine Dimitrakakis,4 Spyridon Marinopoulos,4 Aris Giannos,4 Theodoros N Sergentanis,1 Efstathios Kastritis,1 Evangelos Terpos,1 Meletios-Athanassios Dimopoulos11Department of Clinical Therapeutic, Alexand...

Full description

Bibliographic Details
Main Authors: Kalapanida D, Zagouri F, Gazouli M, Tsiakou A, Zografos E, Dimitrakakis C, Marinopoulos S, Giannos A, Sergentanis TN, Kastritis E, Terpos E, Dimopoulos MA
Format: Article
Language:English
Published: Dove Medical Press 2019-05-01
Series:OncoTargets and Therapy
Subjects:
SNPS
MET T1010I
MET rs40239
triple negative breast cancer
biomarker
Online Access:https://www.dovepress.com/evaluation-of-met-t1010i-and-met-rs40239-single-nucleotide-polymorphis-peer-reviewed-article-OTT

Internet

https://www.dovepress.com/evaluation-of-met-t1010i-and-met-rs40239-single-nucleotide-polymorphis-peer-reviewed-article-OTT

Similar Items